Reply to "Combined antibiotic, steroid, and moisturizer for atopic dermatitis: A 2-year case series of patient-reported outcomes"

Jonathan I Silverberg; Jacob P Thyssen; Emma Guttman-Yassky; Amy S Paller

doi:10.1111/pde.14612

Reply to "Combined antibiotic, steroid, and moisturizer for atopic dermatitis: A 2-year case series of patient-reported outcomes"

Jonathan I Silverberg, Jacob P Thyssen, Emma Guttman-Yassky, Amy S Paller

Dermatologisk og Venerologisk Afdeling og Videncenter for Sårheling BFH

1 Citationer (Scopus)

Originalsprog	Engelsk
Tidsskrift	Pediatric Dermatology
Vol/bind	38
Udgave nummer	3
Sider (fra-til)	736-737
Antal sider	2
ISSN	0736-8046
DOI	https://doi.org/10.1111/pde.14612
Status	Udgivet - maj 2021

Adgang til dokumentet

10.1111/pde.14612

Andre filer og links

Link to publication in Scopus

Citationsformater

@article{8ee2bff414d54663b77f09facc0f8bcc,

title = "Reply to {"}Combined antibiotic, steroid, and moisturizer for atopic dermatitis: A 2-year case series of patient-reported outcomes{"}",

keywords = "efficacy, limitations, safety, tolerability, topical",

author = "Silverberg, \{Jonathan I\} and Thyssen, \{Jacob P\} and Emma Guttman-Yassky and Paller, \{Amy S\}",

year = "2021",

month = may,

doi = "10.1111/pde.14612",

language = "English",

volume = "38",

pages = "736--737",

journal = "Pediatric Dermatology",

issn = "0736-8046",

publisher = "John Wiley and Sons Inc.",

number = "3",

}

TY - JOUR

T1 - Reply to "Combined antibiotic, steroid, and moisturizer for atopic dermatitis

T2 - A 2-year case series of patient-reported outcomes"

AU - Silverberg, Jonathan I

AU - Thyssen, Jacob P

AU - Guttman-Yassky, Emma

AU - Paller, Amy S

PY - 2021/5

Y1 - 2021/5

KW - efficacy

KW - limitations

KW - safety

KW - tolerability

KW - topical

UR - https://www.scopus.com/pages/publications/85109092678

U2 - 10.1111/pde.14612

DO - 10.1111/pde.14612

M3 - Comment/debate

C2 - 34224616

SN - 0736-8046

VL - 38

SP - 736

EP - 737

JO - Pediatric Dermatology

JF - Pediatric Dermatology

IS - 3

ER -